Litcius/Paper detail

In vitro multi-enzymatic cascades using recombinant lysates of E. coli: an emerging biocatalysis platform

Apostolos Alissandratos

2020Biophysical Reviews32 citationsDOIOpen Access PDF

Abstract

In recent years, cell-free extracts (or lysates) have (re-)emerged as a third route to the traditional options of isolated or whole-cell biocatalysts. Advances in molecular biology and genetic engineering enable facile production of recombinant cell-free extracts, where endogenous enzymes are enriched with heterologous activities. These inexpensive preparations may be used to catalyse multistep enzymatic reactions without the constraints of cell toxicity and the cell membrane or the cost and complexity associated with production of isolated biocatalysts. Herein, we present an overview of the key advancements in cell-free synthetic biology that have led to the emergence of cell-free extracts as a promising biocatalysis platform.

Topics & Concepts

BiocatalysisHeterologousSynthetic biologyRecombinant DNAEnzymeHeterologous expressionCellMetabolic engineeringBiochemistryComputational biologyChemistryCell-free protein synthesisIn vitroBiologyBiochemical engineeringGeneProtein biosynthesisCatalysisEngineeringIonic liquidEnzyme Catalysis and ImmobilizationClick Chemistry and ApplicationsMicrobial Metabolic Engineering and Bioproduction
In vitro multi-enzymatic cascades using recombinant lysates of E. coli: an emerging biocatalysis platform | Litcius